# A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

> clinical trial · VERIFIED · 2026-07-20

Status: COMPLETED · Sponsor: AbbVie · Condition: Psoriatic Arthritis (PsA)

- Company: AbbVie
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT03671148

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.
